{"id":46913,"date":"2022-08-04T00:01:39","date_gmt":"2022-08-03T22:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/"},"modified":"2022-08-04T00:01:39","modified_gmt":"2022-08-03T22:01:39","slug":"geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/","title":{"rendered":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference"},"content":{"rendered":"
\n

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 at 12:35 p.m. ET.\n<\/p>\n

<\/a><\/p>\n

\nA webcast of the presentation will be available through the Investor Relations section of Geron\u2019s website under Events<\/a>. Following the presentation, the webcast will be archived and available for replay for a period of 30 days.\n<\/p>\n

\nAbout Geron<\/b>\n<\/p>\n

\nGeron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAron Feingold
\n
Investor and Media Relations
\n
investor@geron.com<\/a>
media@geron.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46913","6":"format-standard","7":"category-industry"},"yoast_head":"\nGeron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-03T22:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference\",\"datePublished\":\"2022-08-03T22:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"wordCount\":165,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220803005004\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"name\":\"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220803005004\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"datePublished\":\"2022-08-03T22:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220803005004\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220803005004\\\/en\\\/1271210\\\/21\\\/Geron_Full_Logo_Pantone-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend","og_description":"FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron\u2019s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-03T22:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference","datePublished":"2022-08-03T22:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/"},"wordCount":165,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/","url":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/","name":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","datePublished":"2022-08-03T22:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220803005004\/en\/1271210\/21\/Geron_Full_Logo_Pantone-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/geron-to-participate-in-the-2022-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46913"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46913\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}